These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6133299)

  • 1. Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic.
    Molander L; Borgström L
    Psychopharmacology (Berl); 1983; 79(2-3):111-4. PubMed ID: 6133299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative effects and prolactin response to single oral doses of melperone.
    Molander L; Borgström L
    Psychopharmacology (Berl); 1983; 79(2-3):142-7. PubMed ID: 6133301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug.
    Refsum H; Amlie JP; Platou ES; Owren T; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):131-6. PubMed ID: 6114796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological data of the atypical neuroleptic compound melperone (Buronil).
    Christensson EG
    Acta Psychiatr Scand Suppl; 1989; 352():7-15. PubMed ID: 2573242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels and cardiac electrophysiological effects of melperone in the dog.
    Platou ES; Refsum H; Amlie JP; Landmark K
    Eur J Pharmacol; 1982 Aug; 82(1-2):1-7. PubMed ID: 7128676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of beta-adrenergic and cholinergic blockade on the electrophysiological effects of melperone in the dog heart in situ.
    Platou ES; Refsum H; Amlie JP; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):137-43. PubMed ID: 6114797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of parenteral and oral melperone in man.
    Borgström L; Larsson H; Molander L
    Eur J Clin Pharmacol; 1982; 23(2):173-6. PubMed ID: 7140807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and effects of methaqualone after single and multiple oral doses in man.
    Alván G; Ericsson O; Levander S; Lindgren JE
    Eur J Clin Pharmacol; 1974 Oct; 7(6):449-54. PubMed ID: 4439868
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-adrenoceptor blockade and class III antiarrhythmic activity combined: hemodynamic and electrophysiological effects of melperone in the dog.
    Platou ES; Myhre ES; Refsum H
    Can J Physiol Pharmacol; 1986 Oct; 64(10):1286-90. PubMed ID: 2879618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of timiperone, 4'-fluoro-4-[4-(2-thioxo-1-benzimidazolinyl)piperidino]butyrophenone, a neuroleptic.
    Sudo K; Tachizawa H
    Chem Pharm Bull (Tokyo); 1983 Apr; 31(4):1411-4. PubMed ID: 6138166
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative analysis of melperone in human plasma by gas chromatography--mass spectrometry--selected ion monitoring.
    Chan KY; Okerholm RA
    J Chromatogr; 1983 May; 274():121-7. PubMed ID: 6135699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsychotic neuroplegics and neuroleptics. VII. Butyrophenones (Part 2)].
    Deligné P; Bunodière M
    Ann Anesthesiol Fr; 1979; 20(4):343-56. PubMed ID: 40495
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of timiperone, 4'-fluoro-4-[4-(2-thioxo-1-benzimidazolinyl)piperidino]butyrophenone, a neuroleptic, in the rat on repeated oral dosage.
    Sudo K; Tachizawa H; Sano M
    Xenobiotica; 1981 Oct; 11(10):685-91. PubMed ID: 6119853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melperone: electrophysiologic and antiarrhythmic activity in humans.
    Hui WK; Mitchell LB; Kavanagh KM; Gillis AM; Wyse DG; Manyari DE; Duff HJ
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):144-9. PubMed ID: 1688972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
    Röhricht F; Gadhia S; Alam R; Willis M
    ScientificWorldJournal; 2012; 2012():512047. PubMed ID: 22566771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological investigations of 4'-fluoro-4-(4-methyl-peperidono)-butyrophenone with respect to its sedative and sleep-inducing properties (author's transl)].
    Kretzschmar R; Otto J; Teschendorf HJ; Worstmann W
    Arzneimittelforschung; 1976; 26(6):1073-6. PubMed ID: 183793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective alpha-adrenoceptor blocking action of melperone.
    Jiang ZW; Liu TP
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):316-20. PubMed ID: 2904206
    [No Abstract]   [Full Text] [Related]  

  • 20. Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.
    Vincent J; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1988 Nov; 26(5):503-8. PubMed ID: 2905151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.